Simvastatin
Peter A. Todd, Karen L. Goa · Drugs · 1990
Cited by 219 works. doi:10.2165/00003495-199040040-00007
Authors
References
- Fat Transport in Lipoproteins — An Integrated Approach to Mechanisms and Disorders
- The Low-Density Lipoprotein Pathway and its Relation to Atherosclerosis
- Mevinolin: a highly potent competitive inhibitor of hydroxymethylglutaryl-coenzyme A reductase and a cholesterol-lowering agent.
- Multivalent feedback regulation of HMG CoA reductase, a control mechanism coordinating isoprenoid synthesis and cell growth.
- ML-236A, ML-236B, and ML-236C, new inhibitors of cholesterogensis produced by Penicillium citrinum.
- Association of coronary atherosclerosis with hyperapobetalipoproteinemia [increased protein but normal cholesterol levels in human plasma low density (beta) lipoproteins].
- HMG-CoA Reductase Inhibitors for Treatment of Hypercholesterolemia
- Regulatory role for hepatic low density lipoprotein receptors in vivo in the dog.
- Report of the National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. The Expert Panel
- Monacolin K, a new hypocholesterolemic agent produced by a Monascus species.